Pitavastatin

What is Pitavastatin?

Pitavastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular disease. Pitavastatin is considered one of the newer statins and is known for having fewer drug interactions compared to some other medications in its class.

Uses

Pitavastatin is prescribed for several cardiovascular conditions:

Primary hyperlipidemia: Treatment of elevated cholesterol levels, including low-density lipoprotein (LDL) cholesterol, when diet and lifestyle changes alone are insufficient.

Mixed dyslipidemia: Management of patients with elevated cholesterol and triglyceride levels, helping to improve overall lipid profiles.

Submit Your Paper

Cardiovascular disease prevention: Reducing the risk of heart attack, stroke, and other cardiovascular events in patients with risk factors such as diabetes, high blood pressure, or existing heart disease.

Familial hypercholesterolemia: Treatment of inherited conditions that cause extremely high cholesterol levels, often used in combination with other lipid-lowering therapies.

Secondary prevention: Long-term management in patients who have already experienced cardiovascular events to prevent future occurrences.

How it works

Pitavastatin works by blocking an enzyme called HMG-CoA reductase, which is responsible for cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the amount of cholesterol the body makes naturally, forcing the liver to remove more cholesterol from the bloodstream. This dual action results in lower total cholesterol and LDL (“bad”) cholesterol levels while potentially increasing HDL (“good”) cholesterol.

Side effects

Common side effects include:

• Muscle pain or weakness
• Headache
• Back pain
• Diarrhea
• Constipation
• Nausea
• Joint pain
• Fatigue

Serious side effects to watch for:

• Severe muscle pain, tenderness, or weakness (signs of myopathy)
• Dark-colored urine or decreased urination (possible rhabdomyolysis)
• Yellowing of skin or eyes, severe abdominal pain (liver problems)
• Unexplained fatigue, loss of appetite, or upper abdominal discomfort
• Memory problems or confusion

Warnings and precautions

Liver disease: Patients with active liver disease or unexplained persistent elevations in liver enzymes should not take pitavastatin. Regular liver function monitoring may be required during treatment.

Pregnancy and breastfeeding: Pitavastatin is contraindicated during pregnancy and breastfeeding, as cholesterol is essential for fetal development and the drug may pass into breast milk.

Kidney impairment: Patients with severe kidney disease require dose adjustments, as the medication’s clearance from the body may be reduced.

Muscle disorders: Individuals with a history of muscle problems or those taking medications that increase muscle toxicity risk should be monitored closely for signs of myopathy.

Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower starting doses.

Interactions

Cyclosporine: Significantly increases pitavastatin levels, requiring dose reduction or alternative therapy due to enhanced toxicity risk.

Gemfibrozil and other fibrates: May increase the risk of muscle toxicity when combined with pitavastatin, requiring careful monitoring.

Niacin (high doses): Can increase the risk of muscle problems when used with statins, particularly in elderly patients.

Warfarin: Pitavastatin may enhance the anticoagulant effect, requiring more frequent INR monitoring and possible dose adjustments.

Digoxin: Statin therapy may increase digoxin levels, necessitating monitoring of digoxin concentrations.

Grapefruit juice: While pitavastatin has fewer interactions with grapefruit compared to other statins, large quantities should still be avoided.

Rifampin: May decrease pitavastatin effectiveness by increasing its metabolism in the liver.

Coenzyme Q10 supplements: While not harmful, some patients take CoQ10 supplements as statins may reduce natural CoQ10 levels.

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose of pitavastatin for adults is 2 mg once daily, taken with or without food. The dose may be adjusted based on individual response and cholesterol targets, with a maximum recommended dose of 4 mg daily. Patients with kidney impairment may require lower doses, starting at 1 mg daily. Dosage adjustments should always be made gradually, typically at 4-week intervals, to allow time for the full cholesterol-lowering effect to develop. Your healthcare provider will determine the appropriate dose based on your specific medical condition, other medications, and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).